Objective: To evaluate the efficacy and safety of renal artery embolization in treatment of complex angiomyolipoma and renal cell carcinoma. Patients and Methods: Twenty patients were included in this study, 11 patients with primary renal cell carcinoma and 9 patients with AML. These patients were examined by US, CT or and MRI before RAE to evaluate size of the tumor, assess extension of renal cell carcinoma, exclude distant metastasis and assess the complications of angiomyolipoma. Renal artery embolization yield, complications and the impact of patient`s management were analyzed. Results: This study included 20 patients (12 males and 8 females). The age range was 17-75 (47.8±15.5) years. The type of renal masses were renal cell carcinoma in 11 patients and angiomyolipoma in 9 patients (5 bilateral and 4 unilateral). According to the modified Clavien system, 4 patients developed Grade I complication (3 patients developed flank pain (15%) treated with oral analgesics and 1 patient (5%) developed self-limiting perinephric hematoma which resolved spontaneously under antibiotic coverage. Conclusion: RAE is a safe, effective and well tolerated treatment of AML either if large sized which is liable to rupture or symptomatic to stop bleeding. Also, it allows preoperative de-vascularization of RCC to facilitate its surgical resection and as palliative treatment if RCC is un-resectable or metastatic.
| Published in | International Journal of Clinical Urology (Volume 6, Issue 1) |
| DOI | 10.11648/j.ijcu.20220601.23 |
| Page(s) | 56-62 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2022. Published by Science Publishing Group |
Renal Artery Embolization, Renal Cell Carcinoma, Angiomyolipoma
| [1] | Cochetti G, Zingaro M, Boni A, Allegritti M, Vermandois J, Paladini A, Egidi M, Poli G, Ursi P, Cirocchi R, Mearini E. Renal artery embolization before radical nephrectomy for complex renal tumour: which are the true advantages?. Open Medicine. 2019; 14 (1): 797-804. |
| [2] | Farg HM, Elawdy MM, Soliman KA, Badawy MA, Elsorougy A, Abdelhamid A, Mohsen T, El-Diasty T. Predictors of renal angioembolization outcome: A retrospective analysis with 148 patients at a tertiary urology institute. Asian Journal of Urology 2022, (9): 2, 103-108. |
| [3] | Li David, Pua BB and Madoff DC. Role of Embolization in the Treatment of Renal Masses. Semin Intervent Radiol.; 31 (1): 70–81, Mar 2014. |
| [4] | Muller A & Rouvière O. Renal artery embolization-indications, technical approaches and outcomes. Nature Reviews Nephrology 11, 288–301 (2015). |
| [5] | Popovic P, Lukic S, Mijailovic M, et al. Percutaneous radiofrequency ablation of small renal cell carcinoma: technique, complications, and outcomes. J BUON. 17 (4): 621-626, 2012. |
| [6] | William R. Sukov and John C. Cheville. Classification of Adult Renal Tumors and Grading of Renal Cell Carcinoma. Genitourinary Pathology, Springer, New York. Chap. 23, 285-297, 2015. |
| [7] | Valji K. Vascular and Interventional Radiology. 2nd ed. Philadelphia: WB Sanders; 171–174, 2006. |
| [8] | Watanabe S, Hama Y, Kaji T, Kimura F, Kosuda S. Pre-operative embolization for spontaneous rupture of renal cell carcinoma. Ulster Med J.; 74: 66–67, 2005. |
| [9] | Zielinski, H., Szmigielski, S. & Petrovich, Z. Comparison of preoperative embolization followed by radical nephrectomy with radical nephrectomy alone for renal cell carcinoma. Am. J. Clin. Oncol. 23, 6–12 (2000). |
| [10] | Loffroy R, Rao P, Kwak BK, et al. Trans catheter Arterial Embolization in Patients with Kidney Diseases: an Overview of the Technical Aspects and Clinical Indications. Xorean J Radiol, 11: 257¬268, 2010. |
| [11] | Schwartz MJ, Smith EB, Trost DW & Vaughan ED. Renal artery embolization: clinical indications and experience from over 100 cases. BJU Int. 99, 881–886 (2007). |
| [12] | Ginat, DT, Saad, WE & Turba, UC. Transcatheter renal artery embolization: clinical applications and techniques. Tech. Vasc. Interv. Radiol. 12, 224–239 (2009). |
| [13] | Kalman D and Varenhorst E. The role of arterial embolization in renal cell carcinoma. Scand J Urol Nephrol.; 33 (3): 162–170, 1999. |
| [14] | Ljungberg B, Cowan N C, Hanbury D C. et al. EAU guidelines on renal cell carcinoma: Eur Urol. 2010; 58 (3): 398–406, the update 2010. |
| [15] | Gervais DA, McGovern FJ, Arellano RS, et al. Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology; 226: 417-424, 2003. |
| [16] | Mahnken AH, Rohde D, Brkovic D, et al. Percutaneous radiofrequency ablation of renal cell carcinoma: preliminary results. Acta Radiol.; 46 (2): 208-214, 2005. |
| [17] | Halpenny D, Snow A, McNeill G, Torreggiani W C. The radiological diagnosis and treatment of renal angiomyolipoma-current status. ClinRadiol.; 65 (2): 99–108, 2010. |
| [18] | Restrepo, J., Millan, D., Sabogal, C., Bernal, A., & Donoso, W. D.. New Trends and Evidence for the Management of Renal Angiomyolipoma: A Comprehensive Narrative Review of the Literature. Journal of kidney cancer and VHL, (2022) 9 (1), 33–41. |
| [19] | Soulen MC, Faykus MH Jr, Shlansky-Goldberg RD et al. Elective embolization for prevention of hemorrhage from renal angiomyolipomas. J VascIntervRadiol.; 5 (4): 587–591, 1994. |
| [20] | Lenton, J., Kessel, D. & Watkinson, A. F. Embolization of renal angiomyolipoma: immediate complications and long-term outcomes. Clin. Radiol. 63, 864–870 (2008). |
| [21] | Katsanos K, Sabharwal T, Ahmad F, Dourado R, Adam A. Onyx embolization of sporadic angiomyolipoma. Cardiovasc Intervent Radiol.; 32 (6): 1291–1295, 2009. |
| [22] | Villalta, J. D., Sorensen, M. D., Durack, J. C., et al. Selective arterial embolization of angiomyolipomas: a comparison of smaller and larger embolic agents. J. Urol. 186, 921–927 (2011). |
| [23] | Chan CK, Yu S, Yip S, Lee P. The efficacy, safety and durability of selective renal arterial embolization in treating symptomatic and asymptomatic renal angiomyolipoma. Urology; 77 (3): 642–648, 2011. |
| [24] | Ewalt, D. H. et al. Long-term outcome of transcatheter embolization of renal angiomyolipomas due to tuberous sclerosis complex. J. Urol. 174, 1764–1766 (2005). |
| [25] | Williams J M, Racadio J M, Johnson N D, Donnelly L F, Bissler J J. Embolization of renal angiomyolipomata in patients with tuberous sclerosis complex. Am J Kidney Dis.; 47 (1): 95–102, 2006. |
| [26] | Kothary N, Soulen MC, Clark TW, Wein AJ, et al. Renal angiomyolipoma: Long-term results after arterial embolization. J Vasc Interv Radiol.; 16: 45–50, 2005. |
| [27] | Lionberg A, Jeffries J, Van Ha TG. Renal Artery Embolization for Neoplastic Conditions. Semin Intervent Radiol. 2020 Oct; 37 (4): 420-425. |
| [28] | Lin P H, Terramani T T, Bush R L, Keane T E, Moore R G, Lumsden A B. Concomitant intraoperative renal artery embolization and resection of complex renal carcinoma. J Vasc Surg.; 38 (3): 446–450, 2003. |
| [29] | Carvajal R, Orgaz A, Leal J I. et al. Renal embolization and nephrectomy in a single surgical act in high-risk renal tumor pathology. Ann Vasc Surg.; 25 (2): 222–228, 2011. |
| [30] | Lee S Y, Hsu H H, Chen Y C. et al. Evaluation of renal function of angiomyolipoma patients after selective transcatheter arterial embolization. Am J Med Sci.; 337 (2): 103–108, 2009. |
APA Style
Ahmed Mohamed Moeen, Mohamed Abdel Basir Sayed, Amro Farouk Mourad, Tarek El-Diasty, Mohamed M. El-Barody. (2022). Safety and Efficacy of Angio-embolization for Complex Renal Cell Carcinoma and Angiomyolipoma: Experience and Results in 20 Patients. International Journal of Clinical Urology, 6(1), 56-62. https://doi.org/10.11648/j.ijcu.20220601.23
ACS Style
Ahmed Mohamed Moeen; Mohamed Abdel Basir Sayed; Amro Farouk Mourad; Tarek El-Diasty; Mohamed M. El-Barody. Safety and Efficacy of Angio-embolization for Complex Renal Cell Carcinoma and Angiomyolipoma: Experience and Results in 20 Patients. Int. J. Clin. Urol. 2022, 6(1), 56-62. doi: 10.11648/j.ijcu.20220601.23
AMA Style
Ahmed Mohamed Moeen, Mohamed Abdel Basir Sayed, Amro Farouk Mourad, Tarek El-Diasty, Mohamed M. El-Barody. Safety and Efficacy of Angio-embolization for Complex Renal Cell Carcinoma and Angiomyolipoma: Experience and Results in 20 Patients. Int J Clin Urol. 2022;6(1):56-62. doi: 10.11648/j.ijcu.20220601.23
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ijcu.20220601.23,
author = {Ahmed Mohamed Moeen and Mohamed Abdel Basir Sayed and Amro Farouk Mourad and Tarek El-Diasty and Mohamed M. El-Barody},
title = {Safety and Efficacy of Angio-embolization for Complex Renal Cell Carcinoma and Angiomyolipoma: Experience and Results in 20 Patients},
journal = {International Journal of Clinical Urology},
volume = {6},
number = {1},
pages = {56-62},
doi = {10.11648/j.ijcu.20220601.23},
url = {https://doi.org/10.11648/j.ijcu.20220601.23},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcu.20220601.23},
abstract = {Objective: To evaluate the efficacy and safety of renal artery embolization in treatment of complex angiomyolipoma and renal cell carcinoma. Patients and Methods: Twenty patients were included in this study, 11 patients with primary renal cell carcinoma and 9 patients with AML. These patients were examined by US, CT or and MRI before RAE to evaluate size of the tumor, assess extension of renal cell carcinoma, exclude distant metastasis and assess the complications of angiomyolipoma. Renal artery embolization yield, complications and the impact of patient`s management were analyzed. Results: This study included 20 patients (12 males and 8 females). The age range was 17-75 (47.8±15.5) years. The type of renal masses were renal cell carcinoma in 11 patients and angiomyolipoma in 9 patients (5 bilateral and 4 unilateral). According to the modified Clavien system, 4 patients developed Grade I complication (3 patients developed flank pain (15%) treated with oral analgesics and 1 patient (5%) developed self-limiting perinephric hematoma which resolved spontaneously under antibiotic coverage. Conclusion: RAE is a safe, effective and well tolerated treatment of AML either if large sized which is liable to rupture or symptomatic to stop bleeding. Also, it allows preoperative de-vascularization of RCC to facilitate its surgical resection and as palliative treatment if RCC is un-resectable or metastatic.},
year = {2022}
}
TY - JOUR T1 - Safety and Efficacy of Angio-embolization for Complex Renal Cell Carcinoma and Angiomyolipoma: Experience and Results in 20 Patients AU - Ahmed Mohamed Moeen AU - Mohamed Abdel Basir Sayed AU - Amro Farouk Mourad AU - Tarek El-Diasty AU - Mohamed M. El-Barody Y1 - 2022/05/24 PY - 2022 N1 - https://doi.org/10.11648/j.ijcu.20220601.23 DO - 10.11648/j.ijcu.20220601.23 T2 - International Journal of Clinical Urology JF - International Journal of Clinical Urology JO - International Journal of Clinical Urology SP - 56 EP - 62 PB - Science Publishing Group SN - 2640-1355 UR - https://doi.org/10.11648/j.ijcu.20220601.23 AB - Objective: To evaluate the efficacy and safety of renal artery embolization in treatment of complex angiomyolipoma and renal cell carcinoma. Patients and Methods: Twenty patients were included in this study, 11 patients with primary renal cell carcinoma and 9 patients with AML. These patients were examined by US, CT or and MRI before RAE to evaluate size of the tumor, assess extension of renal cell carcinoma, exclude distant metastasis and assess the complications of angiomyolipoma. Renal artery embolization yield, complications and the impact of patient`s management were analyzed. Results: This study included 20 patients (12 males and 8 females). The age range was 17-75 (47.8±15.5) years. The type of renal masses were renal cell carcinoma in 11 patients and angiomyolipoma in 9 patients (5 bilateral and 4 unilateral). According to the modified Clavien system, 4 patients developed Grade I complication (3 patients developed flank pain (15%) treated with oral analgesics and 1 patient (5%) developed self-limiting perinephric hematoma which resolved spontaneously under antibiotic coverage. Conclusion: RAE is a safe, effective and well tolerated treatment of AML either if large sized which is liable to rupture or symptomatic to stop bleeding. Also, it allows preoperative de-vascularization of RCC to facilitate its surgical resection and as palliative treatment if RCC is un-resectable or metastatic. VL - 6 IS - 1 ER -
Information
Email: